Patents

US9845330: 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof

The invention relates to newer generation of triazoles, tetrazoles, isoxazoles, urea and sulphonamide functionalities containing 6-nitro-2,3-dihydronitroimidazooxazoles agents of formula 1, their method of preparation, and their use as drugs for treating  Mycobacterium tuberculosis, MDR-TB and XDR-TB either alone or in combination with other anti-tubercular agents. In this invention, new generation 6-nitro-2,3-dihydronitroimidazooxazoles agents also show acceptable pharmacokinetic properties and synergistic or additive effects with known anti-tubercular drugs.

Filing Date: 04-04-2016

Issue Date: 19-12-2017

Applicant: CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu

Patent No: US9845330

Application No: 15/027137

Inventor(s): Parvinder Pal Singh, Gurunadham Munagala, Kushalava Reddy Yempalla, Inshad Ali Khan, Nitin Pal Kalia, Vikrant Singh Rajput, Amit Nargotra, Sanghapal Damodhar Sawant, Ram Asrey Vishwakarma

IPC Classification: C07D 049804, A61K 0031424, A61K 00314439, A61K 0031454, A61K 0031496, A61K 00315377, A61K 004506

Country: United States of America

Related Patents